Similar articles

• A new anorexic agent, WY-5244: cardiovascular actions and influence on sympathomimetic amines.

  Baum T, Gluckman MI. Baum T, et al. J Pharmacol Exp Ther. 1967 Jul;157(1):32-41. J Pharmacol Exp Ther. 1967. PMID: 4382099 No abstract available.
• Cardiovascular stimulant responses following intravenous administration of MJ 9465-2 (2-amino-4-(4-chlorophenyl)-2-imidazoline-HBr) in the dog: mechanisms of action.

  Deitchman D, Gomoll AW, Snyder RW, McKinney GR. Deitchman D, et al. Eur J Pharmacol. 1974 May;26(2):366-74. doi: 10.1016/0014-2999(74)90248-9. Eur J Pharmacol. 1974. PMID: 4152804 No abstract available.
• Cardiovascular actions of a new metabolite of propranolol: isopropylamine.

  Ishizaki T, Privitera PJ, Walle T, Gaffney TE. Ishizaki T, et al. J Pharmacol Exp Ther. 1974 Jun;189(3):626-32. J Pharmacol Exp Ther. 1974. PMID: 4152314 No abstract available.
• Chemical and humoral regulation of blood flow through the precapillary sphincter.

  Altura BM. Altura BM. Microvasc Res. 1971 Oct;3(4):361-84. doi: 10.1016/0026-2862(71)90039-2. Microvasc Res. 1971. PMID: 4400475 Review. No abstract available.
• Adrenergic agents as possible regulators of liver regeneration.

  Morley CG, Royse VL. Morley CG, et al. Int J Biochem. 1981;13(9):969-73. doi: 10.1016/0020-711x(81)90001-x. Int J Biochem. 1981. PMID: 6271611 Review. No abstract available.